XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Notes Receivable From Stockholders
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at beginning of period at Jun. 30, 2021 $ 31 $ 378,451 $ (92) $ (1,220) $ (331,109) $ 46,061
Balance at beginning of period (in shares) at Jun. 30, 2021 31,231          
Interest on stockholders' notes     (2)     (2)
Issuance of common stock upon exercise of stock options   530       530
Issuance of common stock upon exercise of stock options (in shares) 197          
Issuance of common stock in connection with employee stock purchase plan   558       558
Issuance of common stock in connection with employee stock purchase plan (in shares) 65          
Stock-based compensation   5,928       5,928
Foreign currency translation adjustments       (136)   (136)
Net loss         (275) (275)
Balance at end of period at Dec. 31, 2021 $ 31 385,467 (94) (1,356) (331,384) 52,664
Balance at end of period (in shares) at Dec. 31, 2021 31,493          
Balance at beginning of period at Sep. 30, 2021 $ 31 380,969 (93) (1,321) (330,558) 49,028
Balance at beginning of period (in shares) at Sep. 30, 2021 31,387          
Interest on stockholders' notes     (1)     (1)
Issuance of common stock upon exercise of stock options   119       119
Issuance of common stock upon exercise of stock options (in shares) 41          
Issuance of common stock in connection with employee stock purchase plan   558       558
Issuance of common stock in connection with employee stock purchase plan (in shares) 65          
Stock-based compensation   3,821       3,821
Foreign currency translation adjustments       (35)   (35)
Net loss         (826) (826)
Balance at end of period at Dec. 31, 2021 $ 31 385,467 (94) (1,356) (331,384) 52,664
Balance at end of period (in shares) at Dec. 31, 2021 31,493          
Balance at beginning of period at Jun. 30, 2022 $ 32 393,157 (95) (2,687) (333,550) 56,857
Balance at beginning of period (in shares) at Jun. 30, 2022 31,930          
Interest on stockholders' notes     (1)     (1)
Issuance of common stock upon exercise of stock options   465       465
Issuance of common stock upon exercise of stock options (in shares) 129          
Issuance of common stock in connection with employee stock purchase plan   540       540
Issuance of common stock in connection with employee stock purchase plan (in shares) 72          
Stock-based compensation   3,836       3,836
Foreign currency translation adjustments       (206)   (206)
Net loss         (120) (120)
Balance at end of period at Dec. 31, 2022 $ 32 397,998 (96) (2,893) (333,670) 61,371
Balance at end of period (in shares) at Dec. 31, 2022 32,131          
Balance at beginning of period at Sep. 30, 2022 $ 32 395,252 (95) (3,838) (333,566) 57,785
Balance at beginning of period (in shares) at Sep. 30, 2022 31,937          
Interest on stockholders' notes     (1)     (1)
Issuance of common stock upon exercise of stock options   435       435
Issuance of common stock upon exercise of stock options (in shares) 122          
Issuance of common stock in connection with employee stock purchase plan   540       540
Issuance of common stock in connection with employee stock purchase plan (in shares) 72          
Stock-based compensation   1,771       1,771
Foreign currency translation adjustments       945   945
Net loss         (104) (104)
Balance at end of period at Dec. 31, 2022 $ 32 $ 397,998 $ (96) $ (2,893) $ (333,670) $ 61,371
Balance at end of period (in shares) at Dec. 31, 2022 32,131